Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT05292846
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT05292846
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy, Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT05292846. Allocation not applicable; no masking; primary purpose prevention. Start 2022-01-20 (actual); primary completion 2024-02-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures
- Acronym
- DOAC-NOSTOP
- Condition
- Coronary Artery Disease
- Condition
- Bleeding
- Condition
- Direct Acting Anticoagulant Adverse Reaction
- Intervention (Drug)
- Direct-acting oral anticoagulation
- Lead sponsor
- Hospital Universitario La Fe
Record details
- Record id
cardio:ct-nct05292846- Content hash
78cf7e02eee295d31e7b25782f98040fffbe39eebd58675df450ba136685d8d7